Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium
ClinicalTrials.gov ID
NCT02100293
Lead Sponsor
Seoul National University HospitalOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
84Estimated
Last Update Posted
Apr 18, 2016Estimated
Start Date
Oct 2013
Primary Completion Date
Dec 2014Actual
Completion Date
Dec 2014Actual
Brief Summary
This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose rocuronium, intubation condition and surgical condition.
Observation of Neuromuscular Block
Intubation Condition
Surgical Condition
magnesium sulfate 30 mg/kg
saline
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
18-75 yr American Society of Anesthesiologists physical status 1 or 2, BMI of 20-24.9 kg/m2 scheduled for elective laryngeal microsurgery
Exclusion Criteria:
severe respiratory or cardiac disease hepatic or renal function impairment neuromuscular disease on medications affecting neuromuscular function with known allergy to the drugs